Australia - English - Department of Health (Therapeutic Goods Administration)

surgical instruments australia pty ltd - 32859 - bone screw starter - dixi medical bone starter is intended to impact and notch the bone before threading a bone screw into bone.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - 32142 - dialysis start/stop set - to allow the start and stop procedures to be carried out with a patient to perform dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aruma services - 32142 - dialysis start/stop set - various procedure packs used for start/stop procedures performed on a patient undergoing dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

zoll medical australia pty ltd - 46315 - intravascular heating/cooling system start kit - this device is a tubing set, known as a start up kit, and is used in the function of heating or cooling patients to a specific temperature. it typically includes tubing to connect the pump mechanism of the control unit, a heat exchange coil, a spike for insertion into the bag of fluid used in the system (e.g. saline), an air trap, a flow indicator and a luer lock connection for the intravascular catheter.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - venetoclax, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium stearylfumarate; copovidone; polysorbate 80; colloidal anhydrous silica; calcium hydrogen phosphate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - acute myeloid leukaemia,venclexta, as part of combination therapy, is indicated for the treatment of newly diagnosed adult patients with acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.,this medicine has provisional approval in australia for the treatment of newly diagnosed patients with aml who are ineligible for intensive chemotherapy. the decision to approve this indication has been made on the basis of interim data (overall response rate and duration of response). continued approval of this indication depends on verification and description of benefit in confirmatory trials. chronic lymphocytic leukaemia/small lymphocytic lymphoma,venclexta in combination with obinutuzumab is indicated for the treatment of patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll) who are considered unfit or unsuitable for chemo-immunotherapy.,venclexta in combination with rituximab is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.,venclexta monotherapy is indicated for the treatment of:,? patients with relapsed or refractory cll with 17p deletion, or,? patients with relapsed or refractory cll for whom there are no other suitable treatment options.,acute myeloid leukaemia,venclexta, in combination with azacitidine or low-dose cytarabine, is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: microcrystalline cellulose; polysorbate 80; maize starch; croscarmellose sodium; hypromellose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - nebivolol is indicated: to treat essential hypertension; to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - quinagolide hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

itl australia pty ltd - 32142 - dialysis start/stop set - a pre-packed set consisting of the necessary single-use instruments and items required for the start and stop procedures required to be carried out with the patient in order to perform dialysis. the procedure pack provides a selection of items, including pre-filled syringes, for the commencement and completion of haemodialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

itl australia pty ltd - 33963 - intravenous start kit - the iv starter kits will be used to prepare a site for insertion of a cannula. the procedure pack provides the necessary items required to prepare the skin for an iv cannula insertion and fixation. intravenous cannula insertion pack is made without the cannula. the kits contain various combinations of adhesive dressings, alcohol swabs, trays, underpads, gauze and other components.

Australia - English - Department of Health (Therapeutic Goods Administration)

itl australia pty ltd - 33963 - intravenous start kit - the iv starter kits will be used to prepare a site for insertion of a cannula. the procedure pack provides the necessary items required to prepare the skin for an iv cannula insertion and fixation. intravenous cannula insertion pack is made without the cannula. the kits contain various combinations of trays, underpads, gauze and other components.